Navigation Links
According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
Date:9/25/2013

EXTON, Pa., Sept. 25, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, according to oncologists surveyed in Q3 2013, Johnson & Johnson/Janssen Biotech/Janssen-Cilag's Zytiga is the patient-share leader in the first-line asymptomatic and symptomatic metastatic castrate-resistant prostate cancer (mCRPC) settings; respondents in Q1 2013 cited conventional hormone therapy and docetaxel as lead therapies in these respective settings. Surveyed oncologists in Q3 2013 reported that Medivation/Astellas Pharma's Xtandi holds the most patient shares in the second- and third-line mCRPC settings. The findings are from the TreatmentTrends® Prostate Cancer (US) Q3 2013 report, in which 50 urologists and 51 medical oncologists were surveyed about their current and expected treatment practices for prostate cancer.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO)

The report also finds that most surveyed physicians expressed a high level of satisfaction with Zytiga and Xtandi as treatment options for mCRPC. Notably, one-third of respondents also expressed high satisfaction with Algeta/Bayer HealthCare's Xofigo. Consistent with previous waves of research, Dendreon's Provenge and mitoxantrone are associated with the lowest levels of overall satisfaction, according to surveyed physicians.

"The market entry of multiple agents that have prolonged overall survival in pivotal Phase III studies has created an urgent need to understand the optimal sequence in which these therapies should be given," said Decision Resources Group Senior Business Insights Analyst Khurram Nawaz, M.Sc. "When considering the sequence of therapies
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
2. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
3. Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index
4. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
5. Fewer Venture Capital Dollars Invested Into Life Sciences Companies In Q1 2013, According To The MoneyTree Report
6. Food Recalls Driven by Companies Issuing Multiple Recalls in the First Quarter of 2013, According to Latest ExpertRECALL Index
7. Nearly 8 Million Healthcare Personnel Come in Contact with Chemotherapy Drugs, According to CDC
8. Recreational Marijuana Users More Likely To Misuse Prescription Drugs, According to National Study by Quest Diagnostics
9. Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
10. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
11. Hologics 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
(Date:7/28/2014)... FRANCISCO, Calif. , July 28, 2014 ... provided an update on the status of the KB001-A ... with Sanofi Pasteur.  KB001-A Collaboration ... an agreement with Sanofi Pasteur to regain all rights ... and licensing agreement entered into in 2010 has been ...
(Date:7/28/2014)... 2014  Serco Inc., a provider of professional, ... been awarded a re-compete contract to support the ... Deployable Medical Systems.  Serco will provide deployable medical ... world-class healthcare to meet warfighter and humanitarian requirements ... The five year contract has a one-year base ...
Breaking Medicine Technology:STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2
... 14 SARcode Corporation, a privately-held biotechnology company focused ... (LFA-1) antagonists, today announced that Quinton Oswald has joined ... Mr. Oswald brings significant commercial experience and management expertise ... he served as the Vice President & Business Unit ...
... M.D., a 20-year veteran of the consulting and pharmaceutical ... marketing consulting firm ZS Associates as associate principal. ... "I am excited to work with the ZS ... respond to business challenges posed by their internal and ...
Cached Medicine Technology:Quinton Oswald Named Chief Executive Officer of SARcode Corporation 2Quinton Oswald Named Chief Executive Officer of SARcode Corporation 3ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany 2
(Date:7/28/2014)... 2014 The “Tissue Diagnostics ... Digital pathology & Workflow, Special Staining), Disease ... Non Small Cell Lung Cancer and Others), ... companies, Research Laboratories, Contract Research Organizations and ... BRIC, Japan & RoW) - Trends & ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook ... China Surgical Generators market. The report provides value, ... and average prices (in US dollars) within market ... and Argon Plasma Coagulation Generators. , The report ... for each of these market categories, and global ...
(Date:7/28/2014)... 28, 2014 Camp Soaring Eagle ... camp property in Cornville, AZ. The nonprofit organization, ... with the opportunity to attend medically supervised camps ... The organization offers a variety of programs to ... and life threatening illnesses including: Illness Specific Camping ...
(Date:7/28/2014)... Heights, MI (PRWEB) July 28, 2014 ... UHY, introduces the latest edition of UHY International Business ... provided by our members, on the most current business ... around the world. Issue 29 covers the following topics:, ... growth: Which industry sectors will thrive over the next ...
(Date:7/28/2014)... An estimated 68,000 women and men in the ... cancers – an aggressive form of the disease that ... of the body, such as the lungs, liver, bones, ... of Medicine have developed a compound directed at ... blocking tumor cells from “re-seeding.” Their discovery has been ...
Breaking Medicine News(10 mins):Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 3
... the proposal of the Ministry of Health to hike the ... ,"A committee has been set up to review fees charged ... medical sector. This includes the licensing and renewal of licenses ... the medical or health establishments as well," said Dr Ibrahim ...
... Ahmedabad. A man suspected with avian influenza infection ... ,Qadar Abubhai Marghiwala, a 30-year-old resident of ... fever for a week., ,Gujarat's Health Minister ... as primary investigations revealed negative results., ,According ...
... taboo with a study on the mounting violence against women. ... supported with funds from the United Nations Development Fund for ... beaten -- usually by her husband or father. A campaign ... ,In Syria violence against women is usually from ...
... to six times as much sunlight as those with fair ... a new study// . ,Researchers at the Australian ... in the summer sunshine to produce enough Vitamin D whereas ... ,Acceptable levels of sunbathing also depends on geography ...
... people as young as 16 whereas the phenomenon once occurred only ... can escape stress in modern day life. Stress increases glucocorticoid levels. ... hair," Mumbai-based Sonal Shah said. ,"Initially, we used to ... to as low as 16 and 18," Shah told IANS on ...
... A new species that provides the missing evolutionary link between ... onto the land about 375 million years ago//, has been ... a skull, a neck, ribs and parts of the limbs ... ,These fossils, found on Ellesmere Island in Arctic ...
Cached Medicine News:Health News:Stress Can Cause Hair loss at 16 2Health News:Species Linking Fish And Land Animals Found 2Health News:Species Linking Fish And Land Animals Found 3
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
Medicine Products: